IDEX Corporation (IEX) Presents at Oppenheimer 21st Annual Industrial Growth Virtual Conference Transcript
IDEX Corporation (IEX) Presents at Oppenheimer 21st Annual Industrial Growth Virtual Conference Transcript
IEX - IDEX Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$243.57
DETAILS
HIGH:
$257.00
LOW:
$214.00
MEDIAN:
$250.00
CONSENSUS:
$243.57
UPSIDE:
16.66%
Stock News
IDEX Corporation Declares Regular Quarterly Cash Dividend
NORTHBROOK, Ill.--(BUSINESS WIRE)-- #AdvancedManufacturing--IDEX Corp. (NYSE:IEX) announced a regular quarterly cash dividend of $0.73 per common share, its 126th consecutive regular quarterly payment.
IDEX Beats Q1 Earnings Estimates on HST Momentum, Raises View
IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.
IDEX Corporation (IEX) Q1 2026 Earnings Call Transcript
IDEX Corporation (IEX) Q1 2026 Earnings Call Transcript
Idex (IEX) Q1 Earnings and Revenues Top Estimates
Idex (IEX) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.75 per share a year ago.
Is IDEX (IEX) 7.1% Undervalued After Q1 2026 Beat? EPS $1.61 vs $1.41 est., Revenue $886.9M vs $845.57M; GF Score 93/100
Q1 2026 net sales were $886.9 million. The estimated revenue was $845.57 million.GAAP diluted EPS was $1.61. The estimated EPS was $1.41.Adjusted diluted EPS w
IDEX Reports First Quarter Results
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2026. “We delivered a strong first quarter, with results ahead of our expectations led by continued momentum in our growth platforms within our Health & Science Technologies segment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “Our first quarter results demonstrate that our strategy is working, with strong execut.
Cwm LLC Buys 8,537 Shares of IDEX Corporation $IEX
Cwm LLC raised its position in shares of IDEX Corporation (NYSE: IEX) by 144.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,431 shares of the industrial products company's stock after purchasing an additional 8,537 shares during the quarter. Cwm LLC's
IDEX Corporation's Valuation Is Too High Even With Strong Growth
IDEX Corporation has outperformed the S&P 500, with shares up 21.4% since November, driven by rising revenue, profits, and cash flow. IEX remains diversified across industries, with recent growth in Health & Science Technologies fueled by acquisitions and organic gains in semiconductors and aviation. Despite recent gains, IEX appears fairly valued on an absolute basis but trades at a discount relative to peers; a 'hold' rating is maintained.
Idex (IEX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEX Corporation $IEX Shares Sold by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. cut its holdings in IDEX Corporation (NYSE: IEX) by 79.2% in the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 1,468 shares of the industrial products company's stock after selling 5,601 shares during the period. Robeco Institutional Asset Management B.V.'s holdings
Mott Corp. to Offer deltaVision Valve Solutions for Advanced Spacecraft Propulsion Flow Control Systems
FARMINGTON, Conn. and MUNICH, April 17, 2026 /PRNewswire/ -- Mott Corporation will now offer deltaVision's high ‑ performance valve and fluid control solutions to North American spacecraft manufacturers, expanding access to propulsion feed‑system components engineered for reliability, cleanliness, and mission assurance.
Reviewing IDEX (NYSE:IEX) and DNOW (NYSE:DNOW)
IDEX (NYSE: IEX - Get Free Report) and DNOW (NYSE: DNOW - Get Free Report) are both industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Profitability This table compares IDEX and DNOW's net margins, return
IDEX Corporation to Webcast First Quarter 2026 Earnings Call
NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it will release its first quarter 2026 results on Wednesday, April 29, 2026, prior to market open. An investor conference call and webcast will take place at 8:00 a.m. (CT) that same day with Chief Executive Officer and President Eric Ashleman and Senior Vice President and Chief Financial Officer Sean Gillen. The event and associated earnings presentation will be available via webcast in listen-only mode on the.
Brokerages Set IDEX Corporation (NYSE:IEX) PT at $228.22
Shares of IDEX Corporation (NYSE: IEX - Get Free Report) have received an average recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12
Boothbay Fund Management LLC Has $4.92 Million Holdings in IDEX Corporation $IEX
Boothbay Fund Management LLC grew its position in shares of IDEX Corporation (NYSE: IEX) by 1,165.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,247 shares of the industrial products company's stock after buying an additional 27,857 shares during the
IDEX Corporation $IEX Shares Acquired by Aristotle Capital Boston LLC
Aristotle Capital Boston LLC boosted its holdings in IDEX Corporation (NYSE: IEX) by 20.4% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,253 shares of the industrial products company's stock after purchasing an additional 2,925 shares during the quarter. Aristotle Capital Boston
Comparing IDEX (NYSE:IEX) and 3Dx Industries (OTCMKTS:DDDX)
IDEX (NYSE: IEX - Get Free Report) and 3Dx Industries (OTCMKTS:DDDX - Get Free Report) are both industrials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, earnings and profitability. Valuation and Earnings This table compares IDEX and 3Dx
Idex (IEX) Down 4.5% Since Last Earnings Report: Can It Rebound?
Idex (IEX) reported earnings 30 days ago. What's next for the stock?
IDEX Stock Exhibits Strong Prospects Despite Persisting Headwinds
IEX rides strength in the FMT and HST segments, backed by water, pharma and semiconductor demand, while acquisitions like Micro-LAM and Mott expand its tech reach.
Price Targets
Idex Corp. price target raised to $250 from $240 at Seaport Research
$250.00
(was $215.78)
Walt Liptak
·
Seaport Global
Idex Corp. price target raised to $252 from $225 at RBC Capital
$252.00
(was $217.93)
RBC Capital
Idex Corp. price target raised to $250 from $241 at Stifel
$250.00
(was $217.68)
Stifel Nicolaus
Idex Corp. price target raised to $242 from $230 at Oppenheimer
$242.00
(was $217.34)
Oppenheimer
Idex Corp. price target raised to $257 from $247 at Baird
$257.00
(was $217.34)
Robert W. Baird
Idex Corp. price target lowered to $241 from $244 at Stifel
$241.00
(was $205.12)
Stifel Nicolaus
Idex Corp. initiated with a Market Perform at BMO Capital
$214.00
(was $189.73)
BMO Capital
Idex Corp. price target raised to $240 from $197 at Seaport Research
$240.00
(was $212.25)
Seaport Global
Idex Corp. upgraded to Buy from Hold at Argus
$240.00
(was $212.94)
Argus Research
Idex Corp. price target raised to $244 from $211 at RBC Capital
$244.00
(was $211.03)
RBC Capital
Idex Corp. price target raised to $230 from $210 at Oppenheimer
$230.00
(was $209.86)
Bryan Blair
·
Oppenheimer
Idex Corp. price target raised to $247 from $210 at Baird
$247.00
(was $212.25)
Michael Halloran
·
Robert W. Baird
Idex Corp. price target raised to $220 from $200 at Stifel
$220.00
(was $196.43)
Stifel Nicolaus
Idex Corp. price target raised to $211 from $195 at RBC Capital
$211.00
(was $194.99)
RBC Capital
Idex Corp. price target lowered to $195 from $200 at RBC Capital
$195.00
(was $175.97)
RBC Capital
Idex Corp. price target lowered to $191 from $204 at Stifel
$191.00
(was $167.51)
Stifel Nicolaus
Idex Corp. price target lowered to $210 from $212 at Oppenheimer
$210.00
(was $167.05)
Oppenheimer
Idex Corp. price target lowered to $180 from $215 at DA Davidson
$180.00
(was $158.25)
D.A. Davidson
Idex Corp. price target raised to $185 from $175 at Mizuho
$185.00
(was $190.85)
Brett Linzey
·
Mizuho Securities
Idex Corp. price target lowered to $215 from $226 at Baird
$215.00
(was $181.45)
Michael Halloran
·
Robert W. Baird